Business and other management consultancy activities
NICOLINE INVEST AS
Revenue 2024
NOK 250,000
Operating profit
NOK −1.6m
Equity
NOK 131.1m
Incorporated
2005
Share capital
NOK 100,000
Roles
Daglig lederKim Øien
Regnskapsfører
Revisor
Styrets lederKim Øien
VaramedlemAnette Askvig
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| KIM ØIEN | 100.0% | 100.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| FK INVESTMENT AS | Active | 50.0% | 1500.000000 |
| IMMUNOPHARMA AS | Active | 28.9% | 40068866.000000 |
| VISUADO AS | Active | 7.3% | 12140.000000 |
| BLUE HELIX HEALTH AS | Active | 3.2% | 300.000000 |
| MYCOTECH PHARMA AS | Active | 0.7% | 770000.000000 |
| AVA EIENDOM AS | Active | 0.4% | 25899.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.